These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 4679014)
1. Interaction of ascorbic acid and warfarin. Smith EC; Skalski RJ; Johnson GC; Rossi GV JAMA; 1972 Sep; 221(10):1166. PubMed ID: 4679014 [No Abstract] [Full Text] [Related]
2. Interaction of ascorbic acid and warfarin. Hume R; Johnstone JM; Weyers E JAMA; 1972 Mar; 219(11):1479. PubMed ID: 5066913 [No Abstract] [Full Text] [Related]
3. Letter: Interaction of nalidixic acid and warfarin. Hoffbrand BI Br Med J; 1974 Jun; 2(5920):666. PubMed ID: 4600912 [No Abstract] [Full Text] [Related]
4. Aminoglutethimide and warfarin. A new important drug interaction. Lønning PE; Kvinnsland S; Jahren G Cancer Chemother Pharmacol; 1984; 12(1):10-2. PubMed ID: 6690067 [TBL] [Abstract][Full Text] [Related]
5. Warfarin and ascorbic acid: lack of evidence for a drug interaction. Weintraub M; Griner PF Toxicol Appl Pharmacol; 1974 Apr; 28(1):53-6. PubMed ID: 4855406 [No Abstract] [Full Text] [Related]
6. Warfarin resistance linked to enteral nutrition products. Howard PA; Hannaman KN J Am Diet Assoc; 1985 Jun; 85(6):713-5. PubMed ID: 3998343 [No Abstract] [Full Text] [Related]
7. Lack of a clinically important interaction between warfarin and ascorbic acid. Feetam CL; Leach RH; Meynell MJ Toxicol Appl Pharmacol; 1975 Mar; 31(3):544-7. PubMed ID: 1145638 [No Abstract] [Full Text] [Related]
8. A patient with a prolonged prothrombin time due to an adverse interaction between 5-fluorouracil and warfarin. Aki Z; Kotiloğlu G; Ozyilkan O Am J Gastroenterol; 2000 Apr; 95(4):1093-4. PubMed ID: 10763974 [No Abstract] [Full Text] [Related]
9. Biphasic sulphinpyrazone-warfarin interaction. Nenci GG; Agnelli G; Berrettini M Br Med J (Clin Res Ed); 1981 Apr; 282(6273):1361-2. PubMed ID: 6786498 [No Abstract] [Full Text] [Related]
10. Possible interaction between ciprofloxacin and warfarin. Kamada AK DICP; 1990 Jan; 24(1):27-8. PubMed ID: 2301186 [TBL] [Abstract][Full Text] [Related]
11. Standardisation of the laboratory control of anticoagulant therapy. Bradlow BA; Saunders C; Whitbread P; Lurie A; Penfold GK; Metz J S Afr Med J; 1974 Sep; 48(44):1857-62. PubMed ID: 4472316 [No Abstract] [Full Text] [Related]
12. Multisite mucous membrane bleeding due to a possible interaction between warfarin and 5-fluorouracil. Brown MC Pharmacotherapy; 1997; 17(3):631-3. PubMed ID: 9165571 [TBL] [Abstract][Full Text] [Related]
14. Letter: Increased warfarin requirement during mercaptopurine therapy: a new drug interaction. Spiers AS; Mibashan RS Lancet; 1974 Jul; 2(7874):221-2. PubMed ID: 4135641 [No Abstract] [Full Text] [Related]
15. The control of warfarin anticoagulation. A University of Minnesota medical conference. Hammerschmidt DE Minn Med; 1987 Oct; 70(10):585-8. PubMed ID: 3683354 [No Abstract] [Full Text] [Related]
17. Life threatening interaction between tamoxifen and warfarin. Tenni P; Lalich DL; Byrne MJ BMJ; 1989 Jan; 298(6666):93. PubMed ID: 2493305 [No Abstract] [Full Text] [Related]
18. Adverse interaction between warfarin and indomethacin. Chan TY; Lui SF; Chung SY; Luk S; Critchley JA Drug Saf; 1994 Mar; 10(3):267-9. PubMed ID: 7880236 [TBL] [Abstract][Full Text] [Related]
19. Studies in rats on the mechanism by which 6-mercaptopurine inhibits the anticoagulant effect of warfarin. Martini A; Jähnchen E J Pharmacol Exp Ther; 1977 Jun; 201(3):547-53. PubMed ID: 864594 [TBL] [Abstract][Full Text] [Related]